Neovacs S.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
29.90
141.80
147.90
15.40
-
145
Cost of Goods Sold (COGS) incl. D&A
7,870.10
9,753.60
1,575.60
2,714.40
58.40
13,225
Gross Income
7,840.20
9,611.80
1,427.70
2,698.90
58.40
13,080
SG&A Expense
-
-
-
-
18,918.30
10,591
EBIT
7,897.50
9,616.70
12,246.80
17,187.40
19,056.00
13,080
Unusual Expense
10.20
-
-
-
-
-
Non Operating Income/Expense
19.20
53.70
5,048.80
53.90
705.10
3
Interest Expense
149.80
163.10
68.80
99.50
509.30
473
Pretax Income
8,017.40
9,818.40
7,248.20
17,326.90
18,860.20
13,555
Income Tax
1,147.70
2,305.50
2,565.40
3,394.40
4,021.80
2,775
Consolidated Net Income
6,869.70
7,512.90
4,682.70
13,932.50
14,838.40
10,780
Net Income
6,869.70
7,512.90
4,682.70
13,932.50
14,838.40
10,780
Net Income After Extraordinaries
6,869.70
7,512.90
4,682.70
13,932.50
14,838.40
10,780
Net Income Available to Common
6,869.70
7,512.90
4,682.70
13,932.50
14,838.40
10,780
EPS (Basic)
0.34
0.32
0.14
0.32
0.21
0.10
Basic Shares Outstanding
20,272.30
23,617.40
32,982.80
44,062.30
69,243.20
-
EPS (Diluted)
-
-
-
0.32
0.21
-
Diluted Shares Outstanding
-
-
-
44,062.30
69,243.20
-
EBITDA
7,853.90
9,567.10
12,206.30
17,151.00
18,997.60
-
Other Operating Expense
57.40
4.90
10,819.10
14,488.50
79.40
-
Non-Operating Interest Income
39.00
15.10
18.60
13.90
-
-
About Neovacs
View Profile
